Meta Biomed Co., Ltd.
Financials
Valuation Metrics
Meta Biomed Co., Ltd.'s Market Cap is ₩1042B. At end of 2025 it was ₩1350B. Ranked #1222 of 2,436 in KR market (top 50%), #654 of 1,649 on KOSDAQ (top 40%), #44 of 96 in Health Care Equipment & Services (top 46%) by Market Cap.
Investment Metrics(as of 2026-08-04)
| Metric | Value | Rank |
|---|---|---|
| Size | ||
| Market Cap | 104.20B KRW | KR#1,222/2,436 Sec#44/96 |
| Revenue | 99.67B KRW | KR#1,397/2,436 Sec#36/96 |
| Net Income | 9.52B KRW | KR#920/2,436 Sec#25/96 |
| Total Assets | 189.82B KRW | KR#1,311/2,436 Sec#37/96 |
| Net Assets | 127.95B KRW | KR#1,222/2,436 Sec#34/96 |
| Employees | 296 | KR#795/2,436 Sec#23/96 |
| Value | ||
| P/E | 10.95x | KR#765/2,436 Sec#20/96 |
| P/B | 0.81x | KR#1,303/2,436 Sec#25/96 |
| P/S | 1.05x | KR#1,424/2,436 Sec#29/96 |
| EV/EBITDA | 4.22x | KR#172/2,436 Sec#6/96 |
| FCF Yield | -0.45% | KR—/2,436 Sec—/96 |
| Profitability | ||
| ROE | 7.44% | KR#747/2,436 Sec#29/96 |
| ROA | 5.01% | KR#647/2,436 Sec#29/96 |
| Op. Margin | 20.73% | KR#137/2,436 Sec#10/96 |
| Revenue Growth | -11.84% | KR#1,922/2,436 Sec#76/96 |
| Earnings Growth | -22.22% | KR#1,058/2,436 Sec#40/96 |
| Financial Health | ||
| Debt Ratio | 148.36% | KR#1,166/2,436 Sec#60/96 |
| FCF | -471.2M KRW | KR#1,251/2,436 Sec#36/96 |
| Cash | 16.93B KRW | KR#1,344/2,436 Sec#38/96 |
| Current Ratio | 1.55x | KR#1,266/2,436 Sec#67/96 |
| Net Debt/EBITDA | -0.82x | KR#507/2,436 Sec#17/96 |
| Dividend | ||
| Div. Yield | 2.80% | KR#688/2,436 Sec#10/96 |
| Div. Growth | 250.00% | KR#35/2,436 Sec#2/96 |
| Performance | ||
| 1Y Return | -33.30% | KR#1,656/2,436 Sec#51/96 |
| 1M Return | 3.23% | KR#583/2,436 Sec#30/96 |
| From 52W High | -41.89% | KR#845/2,436 Sec#33/96 |
| 1Y MDD | -48.08% | KR#841/2,436 Sec#30/96 |
| Trading | ||
| Volume | 39,770 shares | KR#1,488/2,436 Sec#62/96 |
| Foreign Own. | 5.62% | KR#737/2,436 Sec#23/96 |
| Per Share | ||
| EPS | 358 KRW | KR#1,049/2,436 Sec#30/96 |
| BPS | 4,693 KRW | KR#1,488/2,436 Sec#40/96 |
Company Info
Meta Biomed, established in 1990 and listed on KOSDAQ in 2008, researches, develops, produces, and sells medical devices, including dental materials and suture raw threads. The company has secured a global network with two production and four sales bases, expanding into medical fields by utilizing biocompatible polymer materials. It aims to diversify its medical material business and stabilize its profit structure by developing polymer fillers as a new venture. Meta Biomed was established in 1999 and is headquartered in Cheongju, Chungcheongbuk-do.